Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

opal australasia pty ltd - ethyl and methyl esters of fatty acids; non-ionic surfactants mixture - emulsifiable concentrate - ethyl and methyl esters of fatty acids acid-fatty active 704.0 g/l; non-ionic surfactants mixture emulsifiers & surfactants other 196.0 g/l - adjuvant

European Union - English - EMA (European Medicines Agency)

mylan ireland limited - dimethyl fumarate - multiple sclerosis, relapsing-remitting - immunosuppressants - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

European Union - English - EMA (European Medicines Agency)

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimethyl fumarate - multiple sclerosis, relapsing-remitting - immunosuppressants - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

European Union - English - EMA (European Medicines Agency)

laboratorios lesvi s.l. - dimethyl fumarate - multiple sclerosis, relapsing-remitting - immunosuppressants - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

European Union - English - EMA (European Medicines Agency)

teva gmbh - dimethyl fumarate - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressants - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

European Union - English - EMA (European Medicines Agency)

accord healthcare s.l.u. - dimethyl fumarate - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressants - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

agricultural formulators australia pty ltd - non-ionic surfactant | ethyl and methyl esters of vegetable oil - adjuvant - defoliant additive | desiccant additive | fungicide additive | herbicide additive | insecticide additive | activator | additive - carrier - anti-evaporant | tank mixing | wetting agent (use as directed) | additive | adjuvant | agricultural chemical | evaporant | herbicide | herbicide application | improve penetrating properties | insecticide application | minimise antagonism | spray tank | wetter

United States - English - NLM (National Library of Medicine)

novel laboratories, inc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), sodium bicarbonate (unii: 8mdf5v39qo) (sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), sodium sulfate anhydrous (unii: 36kcs0r750) (sulfate ion - unii:7is9n8kpmg) - polyethylene glycol 3350 240 g in 278.26 g - peg-3350 (240 g) and electrolytes for oral solution, usp with flavor pack is indicated for bowel cleansing prior to colonoscopy or barium enema x-ray examination. peg-3350 (240 g) and electrolytes for oral solution with flavor pack is contraindicated in patients known to be hypersensitive to any of the components. peg-3350 (240 g) and electrolytes for oral solution with flavor pack is contraindicated in patients with ileus, gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis or toxic megacolon.

United States - English - NLM (National Library of Medicine)

carilion materials management - methyldopa (unii: 56lh93261y) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopa anhydrous 250 mg - hypertension. methyldopa is contraindicated in patients: - with active hepatic disease, such as acute hepatitis and active cirrhosis. - with liver disorders previously associated with methyldopa therapy (see ). warnings - with hypersensitivity to any component of this product. - on therapy with monoamine oxidase (mao) inhibitors.

United States - English - NLM (National Library of Medicine)

martin ekwealor pharmaceuticals, inc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p) - polyethylene glycol 3350 17 g in 17 g - for the treatment of occasional constipation. this product should be used for 2 weeks or less as directed by a physician. polyethylene glycol 3350 nf is contraindicated in patients with known or suspected bowel obstruction and patients known to be allergic to polyethylene glycol.